Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway
Pulmonary arterial hypertension (PAH) is a severe disease with a resultant increase of the mean pulmonary arterial pressure, right ventricular hypertrophy and eventual death. Research in recent years has produced various therapeutic options for its clinical management but the high mortality even und...
Guardado en:
Autores principales: | Abraham Tettey, Yujie Jiang, Xiaohui Li, Ying Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/626691f9f4364a179d1a83e96c743654 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pulmonary Hypertension in the Dog
por: Poser Helen, et al.
Publicado: (2016) -
Pulmonary artery dissection in long standing idiopathic pulmonary arterial hypertension: A case report
por: Luis Regalado, BS, MSc, et al.
Publicado: (2022) -
Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Su-Gang Gong, et al.
Publicado: (2021) -
Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices
por: Cosa N, et al.
Publicado: (2016) -
Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats
por: Toshikazu Ito, et al.
Publicado: (2021)